Friederike Sophie Holze

Title: Friederike Sophie Holze: Innovator in Psychedelic Treatment

Introduction

Friederike Sophie Holze is a pioneering inventor based in Naters, Switzerland. She has made significant contributions to the field of psychedelic treatment, particularly in the dosing and administration of LSD for therapeutic purposes. Her innovative approach aims to enhance the positive effects of psychedelics while minimizing negative outcomes.

Latest Patents

Friederike holds a patent for a method of dosing and treating patients with psychedelics. This patent, titled "LSD dose identification," outlines a comprehensive approach to administering psychedelics at various doses, including microdoses and ego-dissolution doses. The method focuses on producing maximum positive subjective acute effects associated with better long-term outcomes while reducing negative acute effects. It also includes techniques for determining the appropriate dose for individuals and monitoring their responses, particularly in treating psychiatric conditions.

Career Highlights

Friederike is affiliated with the University Hospital Basel, where she collaborates with other experts in the field. Her work is instrumental in advancing the understanding of psychedelic therapies and their applications in clinical settings.

Collaborations

One of her notable collaborators is Matthias Emanuel Liechti, with whom she shares insights and research on the therapeutic potential of psychedelics.

Conclusion

Friederike Sophie Holze is a remarkable inventor whose work in psychedelic treatment is paving the way for new therapeutic approaches. Her innovative methods and dedication to research are contributing to the evolving landscape of mental health treatment.